B. Ejlertsen, M.-B. Jensen, and H. T. Mouridsen, “Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer”, AO, vol. 53, no. 2, pp. 174–185, Feb. 2014.